Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

63 results about "Medetomidine" patented technology

Medetomidine is a synthetic drug used as both a surgical anesthetic and analgesic. It is often used as the hydrochloride salt, medetomidine hydrochloride, a crystalline white solid. It is an α2 adrenergic agonist that can be administered as an intravenous drug solution with sterile water.

Medetomidine hapten and preparation method thereof, medetomidine antigen and preparation method thereof, kit and medetomidine detection method

The invention relates to the technical field of biochemical engineering, in particular to a medetomidine hapten, a preparation method of the medetomidine hapten, a medetomidine antigen, a preparation method of the medetomidine antigen, a kit and a medetomidine detection method. The medetomidine hapten is selected from a compound shown in the following structural formula: # imgabs0 #, q is any integer between 1 and 5, and R represents amido or carbonyl. The medetomidine hapten can be used for synthesizing a medetomidine antigen, so that the medetomidine hapten can be used for immunizing to generate an antibody, and adverse reaction caused by using medetomidine or hydrochloride thereof is reduced. Meanwhile, the medetomidine can be applied to rapid diagnosis products such as kits, medetomidine can be simply, conveniently and rapidly detected, and then the phenomenon of drug abuse can be effectively reduced.
Owner:SURE BIOTECH (HANGZHOU) LTD

Dexmedetomidine hydrochloride microneedle as well as preparation method and application thereof

The invention relates to a dexmedetomidine hydrochloride microneedle which is prepared from a drug-loading needle body layer and a substrate layer, the volume ratio of the drug-loading needle body layer to the substrate layer is 1: 100-200, the drug-loading needle body layer is prepared from polyvinylpyrrolidone and dexmedetomidine hydrochloride according to the mass ratio of 1-15: 1, and the substrate layer is prepared from polyethylene glycol diacrylate through photo-crosslinking. The dexmedetomidine hydrochloride microneedle disclosed by the invention has the advantages that the dexmedetomidine hydrochloride microneedle takes effect quickly, is long in drug effect maintenance time, is non-irritant to skin, avoids infection risk, realizes percutaneous precise administration of dexmedetomidine hydrochloride, and remarkably improves bioavailability and medication safety and effectiveness of dexmedetomidine hydrochloride.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Antifouling composition

An antifouling coating composition comprising: (i) a (meth)acrylic silyl ester copolymer comprising at least 15 wt% silyl ester monomers, relative to the total weight of monomers present in the (meth)acrylic silyl ester copolymer; and / or (ii) a (meth)acrylic copolymer comprising 10 wt% or less of silyl ester monomers and 5.0 wt% or less of metal ester monomers, relative to the total weight of monomers present in the (meth)acrylic copolymer, which has a Tg of 10.0 °C or more; (iii) rosin, modified rosin or a metal salt of rosin or a modified rosin; (iv) biocides comprising: a. medetomidine; and b. one or more copper compounds having a copper content of at least 40 wt%, relative to the formula weight of the copper compound, wherein the coating composition as a whole comprises 10.0 wt% or less of biocides; (v) a (meth)acrylic copolymer comprising 10 wt% or less of silyl ester monomers and 5.0 wt% or less of metal ester monomers, relative to the total weight of monomers present in the (meth)acrylic copolymer, which has a Tg below 10.0 °C, preferably below 0 °C, more preferred below - 5 °C, even more preferred below -10 °C, comprising a. monomer of formula II: wherein R4 is H or CH3, and R5 is a C1-C20 hydrocarbyl substituent; and b. 0.5 to 10 wt% of at least one carboxylic acid containing monomer; and (vi) at least 35 wt% of pigments, extenders and biocides combined, relative to the total weight of the coating composition as a whole.
Owner:JOTUN AS

Method for preparing tert-butyl (s)-4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-1-carboxylate and salts thereof and its use in a method for preparing (s)-4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole and salts thereof

The present invention relates to a method for preparing dexmedetomidine ((S)-4-(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole) or a pharmaceutically acceptable salt and / or solvate thereof via the asymmetric hydrogenation of a methylene derivative. The present invention relates also to methods for preparing tert-butyl (S)-4-(1-(2,3-dimethylphenyl)ethyl)-1 / 7-imidazole-1-carboxylate or a pharmaceutically acceptable salt and / or solvate thereof useful in the preparation of dexmedetomidine or its salts.
Owner:MOEHS IBERICA

Application of dexmedetomidine nose drop or nasal spray in preparation of sleep aiding medicine

The invention belongs to the technical field of medical treatment and public health, and particularly relates to a novel application of dexmedetomidine in preparation of a sleep-aiding medicine. The dexmedetomidine has been sold in the market at present as an injection, and is suitable for sedation during tracheal intubation and mechanical ventilation of a surgical patient who is subjected to general anesthesia and sedation of a patient who starts intubation and uses a breathing machine during intensive care treatment. On the basis, the invention provides the application of the nasal dosage form of dexmedetomidine in a new indication insomnia related treatment medicine, and the nasal dosage form has good positive effects in one or more aspects of shortening sleep latency, prolonging sleep time, medicine onset time, lasting action duration and the like, and has better patient acceptability.
Owner:SICHUAN PURITY PHARM CO LTD

Polyphenylene sulfide composite membrane for seawater corrosion prevention and antibiosis and preparation method of polyphenylene sulfide composite membrane

The invention belongs to the field of high polymer materials, and particularly relates to a polyphenylene sulfide composite membrane for seawater corrosion prevention and antibiosis and a preparation method thereof. The invention provides the high-toughness nano-metal molybdate crystal composite polyphenylene sulfide film protection layer, and medetomidine is optionally further added, so that the film protection layer has the functions of corrosion prevention, marine organism adhesion prevention and the like, the corrosion of the marine environment to the surface of a ship is reduced, the adhesion of marine organisms to the surface of the ship is reduced, and the service life of the ship is prolonged. Normal operation of the ship is ensured, maintenance cost is reduced, and service life of the ship is prolonged.
Owner:XIN NING HE KE JI (CHENG DU) YOU XIAN GONG SI

Dexmedetomidine derivative, application thereof and dexmedetomidine transdermal patch preparation quality control or detection method

The invention discloses a dexmedetomidine derivative, application of the dexmedetomidine derivative and a quality control or detection method of a dexmedetomidine transdermal patch preparation, the dexmedetomidine derivative can be used as a standard substance for quality control of the dexmedetomidine transdermal patch preparation, and meanwhile, the invention provides a preparation method of the dexmedetomidine derivative.
Owner:YICHANG HUMANWELL PHARMA CO LTD

Application of dexmedetomidine hydrochloride in preparation of medicine for treating anxiety and fear of pets

The invention provides application of dexmedetomidine hydrochloride in preparation of a pharmaceutical preparation for treating anxiety and fear of pets, and belongs to the technical field of veterinary pharmaceutical preparations. The pharmaceutical preparation is a dexmedetomidine hydrochloride oral soluble film agent and comprises the following components in percentage by weight: 1.0%-10% of dexmedetomidine hydrochloride, 40%-80% of a film-forming agent, 15.0%-35% of a plasticizer and 0.5%-5.0% of a flavoring agent. The dexmedetomidine hydrochloride oral soluble film is used for resisting anxiety and fear of pets caused by noise, travel, medical treatment, new environment and the like, has the advantages of good palatability, smooth surface, uniform drug distribution, good stability, quick dissolution, quick absorption, convenience in clinical use and the like, and has a wide application prospect.
Owner:TIANJIN RINGPU BIO TECHNOLOGY CO LTD

Preparation method of medetomidine

The invention provides a medetomidine preparation method, which comprises: S1, taking 2, 3-dimethyl benzaldehyde as an initial raw material, and carrying out a reaction on the 2, 3-dimethyl benzaldehyde and methylmagnesium chloride to generate 1-(2, 3-dimethyl phenyl) ethanol; s2, excessive silyl group protected imidazole is added into a reaction system in the step S1, and an activated [1-(2, 3-dimethylphenyl) ethyoxyl] silyl ether intermediate is obtained; taking trimethylsilyl trifluoromethanesulfonate as a catalyst, carrying out a Friedel-Crafts reaction with silyl-protected imidazole, and after the reaction is finished, carrying out post-treatment on the reaction liquid to obtain a medetomidine crude product. 2, 3-dimethyl benzaldehyde is adopted as a starting raw material, medetomidine is prepared through a one-pot method, raw materials are cheap, reaction steps are short, the production cost is greatly reduced, TMSOTf is adopted as a catalyst in the Friedel-Crafts reaction, the reaction is efficient, it can be effectively avoided that in the aftertreatment process of a traditional catalyst titanium tetrachloride, a large number of titanic acid colloidal solid insoluble substances are formed, and the yield of medetomidine is increased. The problem that post-treatment layering is difficult is solved, and the yield is increased.
Owner:WUHAN BIOCAUSE PHARMA DEV +1

Metomidine haptens and complete antigens, and methods of making and using the same

PendingCN122355942AImmune profilingMedicine
This invention relates to a medemididine hapten, a complete antigen, and their preparation methods and applications. The structure of the medemididine hapten is shown in Formula I. The preparation method of the medemididine hapten includes: (1) substituting medemididine with ethyl 3-bromopropionate to obtain intermediate 2; (2) adding sodium hydroxide to deprotect the ester group to obtain medemididine hapten 3. The structure of the complete antigen is shown in Formula II. The preparation method of the complete antigen includes: coupling the medemididine hapten with a carrier protein to obtain the complete antigen. This invention discloses a method for preparing medemididine hapten and complete antigen. The synthesis steps are simple and effective, and it can be used in immunoassay. Among them, colloidal gold immunochromatography is simple to operate, has a short detection time, high specificity, and good reproducibility, which can meet the domestic demand for immunoassay of medemididine.
Owner:JIANGSU VOCATIONAL COLLEGE OF MEDICINE

A dexmedetomidine hydrochloride orally disintegrating film and its preparation method and application

The present invention relates to a kind of dexmedetomidine hydrochloride orally disintegrating film, in which the orally disintegrating film contains dexmedetomidine hydrochloride 0.1-10% and film-forming material 90%-99.9% by weight, wherein the film-forming material is selected from any one of copolyvidone, polyethylene caprolactam polyvinyl acetate polyethylene glycol graft copolymer, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, polyvinyl alcohol, polyoxyethylene, povidone, and poloxamer or a combination thereof. The dexmedetomidine hydrochloride orally disintegrating film of the present invention has fast disintegration time in the oral cavity, good mechanical extrusion performance, good film-forming performance, high content uniformity, meets the requirements such as cutting, packaging, transportation and clinical use, significantly improves its dissolution and dissolution rate, stability and bioavailability, and does not need to be taken with water, significantly improves the compliance of children patients, and ensures safe and effective medication.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Dexmedetomidine hydrochloride dissolvable microneedle

The application provides a dexmedetomidine hydrochloride soluble microneedle; the dexmedetomidine hydrochloride soluble microneedle comprises a substrate and a drug-loaded needle body, the drug-loaded needle body comprises dexmedetomidine hydrochloride and a penetration enhancer; the penetration enhancer comprises at least two of laurocapram, polyvinylpyrrolidone and polysorbate; the weight average molecular weight of the polyvinylpyrrolidone is 2000 Da to 13000 Da. The dexmedetomidine hydrochloride soluble microneedle provided by the application can significantly improve the peak drug concentration after transdermal delivery under the promotion of the penetration enhancer, has a short onset time and a long duration, and can achieve the effects of rapid release, rapid onset and sustained effectiveness.
Owner:BEIJING TIDE PHARMACEUTICAL CO LTD

Application of dexmedetomidine in preparation of medicine for promoting morphine addiction fading

The invention provides application of dexmedetomidine in preparation of a medicine for promoting morphine addiction fading, and relates to the technical field of opioid medicine addiction fading. According to the application, it is found for the first time that dexmedetomidine can play a new role in promoting regression of addiction, and clinical application of dexmedetomidine is improved. Dexmedetomidine is widely applied clinically, no related research shows that addiction can be caused by long-time use of dexmedetomidine at present, the effect of promoting the fading of morphine addiction of mice by adopting dexmedetomidine can generate a remarkable effect in a short time, no obvious adverse reaction is seen, and the application has the characteristics of safety and feasibility. Dexmedetomidine is convenient and rapid to administrate and good in compliance, and has very strong clinical applicability in the aspect of promoting morphine addiction fading.
Owner:THE FIRST PEOPLES HOSPITAL OF FOSHAN

A dexmedetomidine compound mouthwash for postoperative analgesia in orthopedics and its preparation method

This invention discloses a dexmedetomidine compound mouthwash for postoperative analgesia in orthopedic surgery and its preparation method. The active ingredients of the mouthwash consist of dexmedetomidine, flurbiprofen, dextropanthenol, and levonorgestrel, wherein the concentration of dexmedetomidine is 0.05–0.2 mg / ml, the concentration of flurbiprofen is 0.2–1 mg / ml, the concentration of dextropanthenol is 1–10 mg / ml, and the concentration of levonorgestrel is 1–3 mg / ml. This mouthwash can achieve four effects: immediate analgesia, nerve block, anti-inflammatory analgesia, and mucosal repair. Experiments have shown that the mouthwash takes effect within 1–2 minutes after administration through the oral mucosa, and the analgesic effect can last for more than 6 hours. It also has a significant synergistic inhibitory effect on inflammatory factors TNF-α, IL-6, and PGE2. The preparation process of this invention is simple, has good stability, and is suitable for industrial production. It can be used for postoperative pain management in orthopedic surgeries such as joint replacement, internal fixation of fractures, and spinal fusion.
Owner:SECOND AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY (INSTITUTE OF ORTHOPEDICS INNER MONGOLIA AUTONOMOUS REGION)

Medetomidine artificial hapten, artificial antigen and preparation method and application thereof

The invention provides a medetomidine artificial hapten, an artificial antigen as well as a preparation method and application of the medetomidine artificial hapten and the artificial antigen. Specifically, the invention provides a medetomidine artificial hapten of formula (X), the artificial hapten maximally retains the characteristic structure of medetomidine, has an active group capable of being coupled with carrier protein, can be used as an antigenic determinant, and has high sensitivity during immunoassay; furthermore, the invention provides a medetomidine artificial antigen based on the medetomidine artificial hapten, and the medetomidine artificial antigen can be applied to colloidal gold immunochromatography detection of medetomidine and has relatively high sensitivity, detection gradient and relatively good specificity.
Owner:HANGZHOU BOYUE BIOTECHNOLOGY CO LTD

Composition for protecting wood from marine wood borers

Embodiments of the present invention relate to a method of reducing or preventing infestation of marine wood-boring insects to wood in a marine environment by impregnating the wood with a composition comprising medetomidine or an enantiomer, salt or base thereof.
Owner:I TECH AB

Composition for relieving beef cattle transportation stress syndrome and application thereof

The invention provides a composition for relieving beef cattle transportation stress syndrome and application thereof, the composition is prepared by premixing dexmedetomidine hydrochloride, gastrodin and normal saline for injection according to the mass concentration ratio, the concentration of dexmedetomidine hydrochloride is 60-65 g / mL, and the concentration of gastrodin is 20-30 mg / mL. The composition is applied to beef cattle before transportation, the composition is intramuscularly injected, and the total injection volume is 10-20 mL. After the composition is injected before beef cattle transportation, immune dysfunction can be effectively improved, excessive HPA axis activation is inhibited, cortisol secretion is reduced, oxidative damage is relieved, and the stability of intestinal flora is maintained, so that inflammation is relieved, nervous excitability is reduced, calming and anxiety resisting effects are achieved, beef cattle transportation stress response is reduced, and the beef cattle transportation effect is improved. And the method is simple to operate and low in cost, and provides theoretical and practical support for preventing the beef cattle transportation stress syndrome.
Owner:HUAZHONG AGRI UNIV

Synthesis process of low catalytic consumption and high optical purity dexmedetomidine hydrochloride and low irritation injection

The application discloses a synthesis process of low-catalyst-consumption high-optical-purity dexmedetomidine hydrochloride and a low-irritation injection, and belongs to the technical field of medical chemical engineering and pharmaceutical preparations. The synthesis process takes 2,3-dimethylacetophenone as raw material, and a unique vinyl imidazole intermediate is synthesized through palladium catalytic coupling of a p-toluenesulfonyl hydrazone intermediate; then, asymmetric catalytic hydrogenation is carried out in the presence of potassium iodide by using an (R)-BINAP-Rh catalytic system; and finally, dexmedetomidine hydrochloride is obtained through salification and purification. The process significantly inhibits the poisoning effect of an imidazole ring on a catalyst, high-optical-purity products can be obtained under a lower hydrogen pressure, chiral resolution is not needed, and the total yield is high. The low-irritation injection is prepared by using a specific process of full low-temperature and low-oxygen on the basis of the high-purity raw medicine. The synthesis process provided by the application has the advantages of mild process conditions, low catalyst consumption and suitability for industrial production; and the prepared injection has the advantages of excellent stability, low irritation and important clinical application value.
Owner:JIANGXI GANNAN HAIXIN PHARMA

Antifouling coating composition

Provided is an antifouling coating composition which is capable of forming an antifouling coating film that has both excellent stood antifouling properties and excellent stood antifouling properties after long-term dynamic immersion, and also has excellent adhesion and peeling resistance to a primer coating film and an intermediate coating film, and also has excellent adhesion to an old antifouling coating film. The antifouling coating composition according to the present invention contains (A) a hydrolyzable polymer containing a metal ester group, (B) medetomidine, (C) bromo-pyrrolic nitrile, (D) copper pyrithione, and (E) a linear or branched alkyl carboxylic acid having 4-30 carbon atoms. The polymer (A) contains a structural unit derived from a metal ester group-containing monomer (a1) represented by formula (1) and / or a structural unit derived from a metal ester group-containing monomer (a2) represented by formula (2). In formula (1), R11 each independently represents a monovalent group containing a terminal ethylenically unsaturated group, and M represents a copper atom or a zinc atom. In formula (2), R21 represents a monovalent group containing a terminal ethylenically unsaturated group, R22 represents a monovalent organic group having 1-30 carbon atoms and not containing a terminal ethylenically unsaturated group, and M represents a copper atom or a zinc atom. # imgabs0 # imgabs1 #
Owner:CHUGOKU MARINE PAINTS

Dexmedetomidine sustained-release microneedle and preparation process thereof

The invention provides a dexmedetomidine sustained-release microneedle and a preparation process thereof. The dexmedetomidine sustained-release microneedle comprises a first section of matrix containing 3.5 W% of hyaluronic acid and 3.5 W% of polyvinylpyrrolidone, the matrix is degraded within about 10 minutes and can provide rapid preliminary drug release, and a second section of matrix containing 15 W% of polyvinyl methyl ether-alt-maleic acid, the matrix is slowly degraded within about 3 hours and can provide rapid preliminary drug release. And sustained drug release is provided. According to the dexmedetomidine sustained-release microneedle and the preparation process thereof, the sustained-release microneedle adopts a two-section structure, and high-performance materials such as hyaluronic acid, polyvinylpyrrolidone and polyvinyl methyl ether-alt-maleic acid are combined, so that the release process of a medicine is divided into two stages of quick effect taking and long-acting sustained release. The first section of matrix is degraded within 10 minutes, 30% of medicine can be rapidly released, and rapid effect taking is achieved.
Owner:曹莹

Dexmedetomidine film agent and preparation method thereof

The invention relates to a dexmedetomidine film agent and a preparation method thereof, the prescription components of the dexmedetomidine film agent comprise dexmedetomidine or a pharmaceutically acceptable salt thereof and a film-forming agent, and the mass ratio of dexmedetomidine to the film-forming agent is 1: (20-200); the film-forming agent is glucose polymer ether. The glucose polymer ether can be a cellulose ether derivative and / or a starch ether derivative. When the glucose polymer ether is a starch ether derivative, the formula further comprises a plasticizer. The preparation method comprises the following steps: coating slurry to prepare a film, and drying; the slurry comprises the prescription components of the dexmedetomidine and water. And the obtained film agent product is stable in quality.
Owner:SHANGHAI ZHONGXI PHARMACEUTICAL CO LTD

A method for detecting enantiomers of dexmedetomidine hydrochloride injection

ActiveCN115616104Beasy to separateReduce stepsComponent separationOther chemical processesPotassium hexafluorophosphateInjection volume
The present invention is specifically a detection method for enantiomers of dexmedetomidine hydrochloride injection, which solves the problem that the high concentration of salt denatures the filler and the cumbersome detection method leads to inaccurate detection results in the existing detection method for enantiomers of dexmedetomidine hydrochloride injection. A detection method for enantiomers of dexmedetomidine hydrochloride injection, comprising the following steps: test solution: dexmedetomidine hydrochloride injection; chromatographic conditions: high performance liquid chromatograph; Chiralcel OD-RH chromatographic column, with cellulose-tris (3,5-dimethylphenylcarbamate) coated silica gel as filler; acetonitrile-potassium hexafluorophosphate solution with a volume ratio of 35:65 as mobile phase; flow rate of 0.5ml / min; injection volume of 10μl; detection wavelength of 220nm; column temperature of 30°C; chromatographic peak determination: inject the test solution into the high performance liquid chromatograph, record the chromatogram, and calculate the content of enantiomers in the test sample by area normalization method. The present invention improves detection accuracy and detection efficiency.
Owner:SHANXI YUANYANG PHARMA TECH

Anti-medetomidine monoclonal antibody as well as application and product thereof

The invention provides an anti-medetomidine monoclonal antibody as well as application and a product thereof, and relates to the technical field of biology. Medetomidine is used for immunizing a Balb / c mouse, splenocytes of the mouse are fused with myeloma cells, hybridoma cells with high specificity are obtained through specific high-throughput screening, a large amount of mouse ascites is obtained through culture and re-immunization, and the mouse ascites with high specificity is obtained. And the medetomidine monoclonal antibody with high purity, high sensitivity and high specificity is obtained through multi-step separation and purification, so that a required raw material is provided for developing an immune test strip for detecting medetomidine. The anti-medetomidine monoclonal antibody disclosed by the invention can be used for immunological detection such as immunoblotting and immunofluorescence, and the obtained antibody is proved to have good specific binding capacity.
Owner:SURE BIOTECH (HANGZHOU) LTD

Dexmedetomidine freeze-dried composition and preparation method thereof

The invention relates to biological medicine manufacturing, in particular to a dexmedetomidine freeze-dried composition and a preparation method thereof.The freeze-dried composition comprises active pharmaceutical ingredients and auxiliary materials, the active pharmaceutical ingredients in unit dosage are smaller than 200 micrograms, and the auxiliary materials comprise a skeleton supporting agent, an adhesive, edible essence and a sweetening agent; the skeleton supporting agent, the adhesive and the sweetening agent are all water-soluble. The freeze-drying composition disclosed by the invention can be disintegrated in the oral cavity, and the defect that the dosage of the taken medicine is greatly changed due to the condition that microgram-level effective component freeze-drying preparations stick to the bottom or fall off residues in the preparation process is overcome. In addition, the freeze-dried composition can be rapidly absorbed in the oral cavity and rapidly take effect, the first-pass effect is reduced, and the bioavailability is improved.
Owner:GUANGJUNHENG (BEIJING) BIOTECHNOLOGY CO LTD +1

A preparation method of dexmedetomidine hydrochloride

The invention discloses a preparation method of dexmedetomidine hydrochloride. First, 2', 3'-dimethylacetophenone is used as raw material. Under Lewis acid catalysis, chlorination reaction occurs with dimethylchlorosilane to synthesize 1-(1-chloroethyl)-2,3-dimethylbenzene. Then, under chiral catalyst catalysis, cross-reduction coupling reaction occurs with 4-iodoimidazole, and finally salification is performed to obtain dexmedetomidine hydrochloride with an enantiomeric excess of up to 99%. The method has the advantages of easy availability of raw materials, simple operation, mild reaction conditions, short synthesis route, high yield, good stereoselectivity, and good economic and social benefits.
Owner:ZHEJIANG NORMAL UNIV

Dexmedetomidine transdermal patch as well as preparation method and application thereof

The invention provides a dexmedetomidine transdermal patch which comprises a backing layer, a release film and a polymer matrix layer arranged between the backing layer and the release film, the polymer matrix layer comprises dexmedetomidine, povidone and a pressure-sensitive adhesive, based on the total mass of the polymer matrix layer, the dexmedetomidine accounts for 4-10%, the povidone accounts for 5-10%, and the pressure-sensitive adhesive accounts for 5-10%. The povidone accounts for 2-12%, and the pressure-sensitive adhesive accounts for 78-94%; the pressure-sensitive adhesive comprises at least one of polymers containing carboxyl or hydroxyl functionalization.
Owner:BEIJING TIDE PHARMACEUTICAL CO LTD

Dexmedetomidine microneedle patch as well as preparation method and application thereof

The invention relates to a dexmedetomidine microneedle patch as well as a preparation method and application thereof. The dexmedetomidine microneedle patch comprises a substrate and a needle body arranged on the surface of the substrate, wherein the needle body comprises dexmedetomidine hydrochloride, a framework material and a penetration enhancer; the penetration enhancer is prepared from one or more of dodecyl-beta-D-maltoside, ethylenediamine tetraacetic acid and tetrahydropiperine. The dexmedetomidine microneedle patch is higher in medicine cumulative penetration amount, facilitates shortening of sleep-aiding onset time and prolonging of sleep-aiding action time, and has a good insomnia treatment effect.
Owner:GUANGZHOU NOVAKEN PHARM CO LTD

Preparation method of dexmedetomidine hydrochloride

The invention discloses a preparation method of dexmedetomidine hydrochloride. Firstly, 2 ', 3'-dimethyl acetophenone is used as a raw material and is subjected to a chlorination reaction with dimethylchlorosilane under catalysis of Lewis acid to synthesize 1-(1-chloroethyl)-2, 3-dimethylbenzene, then under catalysis of a chiral catalyst, 1-(1-chloroethyl)-2, 3-dimethylbenzene and 4-iodoimidazole are subjected to a cross-reduction coupling reaction, and finally salifying is performed to obtain dexmedetomidine hydrochloride with the enantiomer excess percentage as high as 99%. The method has the advantages of easily available raw materials, simple operation, mild reaction conditions, short synthesis route, high yield, good stereoselectivity and the like, and has good economic and social benefits.
Owner:ZHEJIANG NORMAL UNIV

External patch for preoperative sedation and preparation method thereof

A preparation method of an external patch for preoperative sedation relates to the field of medical preparations containing organic effective components, and sequentially comprises the steps of preparing a main component pretreatment substance, preparing a matrix solution, preparing an ointment-containing paste and synthesizing the patch, the preparation method of the main component pretreatment substance comprises the following steps: preparing a mixed liquid by taking dexmedetomidine hydrochloride and floperidol as main components, carrying out spray granulation to obtain a composite solid dispersion, crushing the composite solid dispersion into powder, and mixing and stirring the powder with paraffin oil and superfine silica powder. In the patch prepared from dexmedetomidine hydrochloride and floperidol, the effective components can quickly penetrate through the skin mucous membrane, so that the effect of quickly taking effect is achieved, and a good sedative effect is achieved. The dispersion uniformity of main components in the patch is excellent, the RSD is within 2%, and the effect consistency of the patch is guaranteed. According to the dexmedetomidine hydrochloride tablet, the stability of dexmedetomidine hydrochloride is effectively improved, components are prevented from being decomposed in the long-term storage process, other impurities are not generated, and the shelf life is effectively prolonged to 24 months.
Owner:CHONGQING MATERNAL & CHILD HEALTH HOSPITAL (CHONGQING OBSTETRICS & GYNECOLOGY HOSPITAL CHONGQING INST OF GENETICS & REPRODUCTION)

Superhydrophobic Anti-fouling crayon having capsaicin, medetomidine and other macrofouling inhibitors that is transparent to electronic sensors

A superhydrophobic anti-fouling crayon comprises a composition of capsaicin, wax, polydimethylsiloxane (PDMS), polytetrafluoroethylene (PTFE), and triglyceride, where the crayon is water insoluble, superhydrophobic, and transparent to electronic sensor and antennae signals. The crayon is rubbed onto the marine surface such that a layer of the composition of the crayon is applied thereto to produce a durable coating that inhibits fouling.
Owner:BARNACLE-BLOCKER LLC